Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk of Recurrent Urethral Stricture After Treatment With Paclitaxel-Coated Dilatation Balloon (Optilume) Compared With Non-coated Dilatation Balloon - a Prospective Randomised Multicentre Study

NCT06795074 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT06795074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06795074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk of Recurrent Urethral Stricture After Treatment With Paclitaxel-Coated Dilatation Balloon (Optilume) Compared With Non-coated Dilatation Balloon - a Prospective Randomised Multicentre Study
Lead sponsor
Vastra Gotaland Region
Phase
Phase 4
Overall status
Recruiting
Start date
January 16, 2026
Completion date
February 28, 2031
Enrollment
230 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

urethral stricture